revealed that CXCL11, as a myeloid activation (MA) signature gene, had a positive correlation with the presence of M1 macrophages, mature dendritic cells (DC) and CD8+ T cells in cutaneous melanoma patients (26). This evidence concerns the gene CD8A and cutaneous melanoma.